{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T14:28:29Z","timestamp":1648736909904},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","interventional.theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Interventional Cardiology Clinics"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.iccl.2017.05.007","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T00:40:39Z","timestamp":1504658439000},"page":"525-538","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Current Dataset for Patent Foramen Ovale Closure in Cryptogenic Stroke"],"prefix":"10.1016","volume":"6","author":[{"given":"Olufunso W.","family":"Odunukan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.iccl.2017.05.007_bib1","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1161\/CIR.0000000000000350","article-title":"Heart disease and stroke statistics-2016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.iccl.2017.05.007_bib2","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/01.CIR.0000017498.88393.44","article-title":"Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study","volume":"105","author":"Homma","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.iccl.2017.05.007_bib3","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1212\/CPJ.0000000000000086","article-title":"Cryptogenic stroke: a diagnostic challenge","volume":"4","author":"Yaghi","year":"2014","journal-title":"Neurol Clin Pract"},{"issue":"18","key":"10.1016\/j.iccl.2017.05.007_bib4","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM198805053181802","article-title":"Prevalence of patent foramen ovale in patients with stroke","volume":"318","author":"Lechat","year":"1988","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.iccl.2017.05.007_bib5","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1747-4949.2012.00843.x","article-title":"The risk of paradoxical embolism (RoPE) study: initial description of the completed database","volume":"8","author":"Thaler","year":"2013","journal-title":"Int J Stroke"},{"issue":"1","key":"10.1016\/j.iccl.2017.05.007_bib6","first-page":"60","article-title":"The role of patent foramen ovale in cryptogenic stroke","volume":"53","author":"Senadim","year":"2016","journal-title":"Noro Psikiyatr Ars"},{"issue":"7","key":"10.1016\/j.iccl.2017.05.007_bib7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1212\/WNL.0b013e3182a08d59","article-title":"An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke","volume":"81","author":"Kent","year":"2013","journal-title":"Neurology"},{"issue":"19","key":"10.1016\/j.iccl.2017.05.007_bib8","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1161\/CIRCULATIONAHA.107.757013","article-title":"Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale and cryptogenic stroke: to close or not to close? Closure: what else!","volume":"118","author":"Windecker","year":"2008","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.iccl.2017.05.007_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1212\/WNL.0b013e3181aa2a19","article-title":"Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis","volume":"73","author":"Almekhlafi","year":"2009","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.iccl.2017.05.007_bib10","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/STROKEAHA.111.631648","article-title":"Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence","volume":"43","author":"Kitsios","year":"2012","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.iccl.2017.05.007_bib11","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jcin.2008.12.015","article-title":"Percutaneous device closure of patent foramen ovale in patients with presumed cryptogenic stroke or transient ischemic attack: the Mayo Clinic experience","volume":"2","author":"Ford","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.iccl.2017.05.007_bib12","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jacc.2004.05.044","article-title":"Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke","volume":"44","author":"Windecker","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.iccl.2017.05.007_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/MAJ.0b013e3181592278","article-title":"Cryptogenic stroke in a patient with a PFO: a decision analysis","volume":"335","author":"Stern","year":"2008","journal-title":"Am J Med Sci"},{"issue":"7","key":"10.1016\/j.iccl.2017.05.007_bib14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcin.2012.02.021","article-title":"Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism","volume":"5","author":"Agarwal","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"issue":"35","key":"10.1016\/j.iccl.2017.05.007_bib15","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1093\/eurheartj\/ehv252","article-title":"Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis","volume":"36","author":"Kent","year":"2015","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.iccl.2017.05.007_bib16","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.iccl.2017.05.007_bib17","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1161\/01.CIR.86.6.1902","article-title":"Transcatheter closure of patent foramen ovale after presumed paradoxical embolism","volume":"86","author":"Bridges","year":"1992","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.iccl.2017.05.007_bib18","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1161\/STROKEAHA.109.547828","article-title":"Patent foramen ovale in cryptogenic stroke: incidental or pathogenic?","volume":"40","author":"Alsheikh-Ali","year":"2009","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.iccl.2017.05.007_bib19","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/CIRCULATIONAHA.111.030494","article-title":"Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism","volume":"125","author":"Wahl","year":"2012","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.iccl.2017.05.007_bib20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4244\/EIJV8I3A53","article-title":"PFO closure with the Premere PFO closure device: acute results and follow-up of 263 patients","volume":"8","author":"Stanczak","year":"2012","journal-title":"EuroIntervention"},{"issue":"3","key":"10.1016\/j.iccl.2017.05.007_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1540-8183.2010.00612.x","article-title":"Percutaneous patent foramen ovale closure using Helex and Amplatzer devices without intraprocedural echocardiographic guidance","volume":"24","author":"Siddiqui","year":"2011","journal-title":"J\u00a0Interv Cardiol"},{"issue":"6","key":"10.1016\/j.iccl.2017.05.007_bib22","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/ccd.26080","article-title":"Patent foramen ovale closure following cryptogenic stroke or transient ischaemic attack: long-term follow-up of 301 cases","volume":"86","author":"Mirzaali","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.iccl.2017.05.007_bib23","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3349\/ymj.2016.57.3.621","article-title":"Comparison of outcomes after device closure and medication alone in patients with patent foramen ovale and cryptogenic stroke in Korean population","volume":"57","author":"Moon","year":"2016","journal-title":"Yonsei Med J"},{"issue":"11","key":"10.1016\/j.iccl.2017.05.007_bib24","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jcin.2012.08.009","article-title":"Percutaneous device closure of patent foramen ovale for cryptogenic strokes\/transient ischemic attacks","volume":"5","author":"Freund","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.iccl.2017.05.007_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.003470","article-title":"Propensity score-based analysis of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale: the IPSYS registry (Italian Project on Stroke in Young Adults)","volume":"9","author":"Pezzini","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"issue":"11","key":"10.1016\/j.iccl.2017.05.007_bib26","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.iccl.2017.05.007_bib27","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.iccl.2017.05.007_bib28","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","article-title":"Closure of patent foramen ovale versus medical therapy after cryptogenic stroke","volume":"368","author":"Carroll","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.iccl.2017.05.007_bib29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11886-014-0477-4","article-title":"Current status of percutaneous PFO closure","volume":"16","author":"Rohrhoff","year":"2014","journal-title":"Curr Cardiol Rep"},{"issue":"8","key":"10.1016\/j.iccl.2017.05.007_bib30","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jacc.2015.12.023","article-title":"Device closure of patent foramen ovale after stroke: pooled analysis of completed randomized trials","volume":"67","author":"Kent","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"43","key":"10.1016\/j.iccl.2017.05.007_bib31","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1093\/eurheartj\/eht283","article-title":"Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale","volume":"34","author":"Hornung","year":"2013","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.iccl.2017.05.007_bib32","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/eurheartj\/ehu292","article-title":"Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis","volume":"36","author":"Stortecky","year":"2015","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.iccl.2017.05.007_bib33","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.amjcard.2014.12.051","article-title":"Meta-analysis of net long-term benefit of different therapeutic strategies in patients with cryptogenic stroke and patent foramen ovale","volume":"115","author":"Patti","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.iccl.2017.05.007_bib34","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2261-13-116","article-title":"Transcatheter patent foramen ovale closure versus medical therapy for cryptogenic stroke: a meta-analysis of randomized clinical trials","volume":"13","author":"Riaz","year":"2013","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"10.1016\/j.iccl.2017.05.007_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4330\/wjc.v6.i1.1","article-title":"Percutaneous closure of patent foramen ovale: \u201cclosed\u201d door after the last randomized trials?","volume":"6","author":"Hernandez","year":"2014","journal-title":"World J Cardiol"},{"issue":"4","key":"10.1016\/j.iccl.2017.05.007_bib36","doi-asserted-by":"crossref","first-page":"JC4","DOI":"10.7326\/0003-4819-159-4-201308200-02004","article-title":"ACP Journal Club. Patent foramen ovale closure and medical therapy did not differ for recurrence after cryptogenic stroke","volume":"159","author":"Sharma","year":"2013","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.iccl.2017.05.007_bib37","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.amjcard.2014.08.027","article-title":"Cost effectiveness of percutaneous closure versus medical therapy for cryptogenic stroke in patients with a patent foramen ovale","volume":"114","author":"Pickett","year":"2014","journal-title":"Am J Cardiol"},{"issue":"1\u20132","key":"10.1016\/j.iccl.2017.05.007_bib38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jns.2008.08.018","article-title":"Cryptogenic stroke and patent foramen ovale: clinical clues to paradoxical embolism","volume":"275","author":"Ozdemir","year":"2008","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.iccl.2017.05.007_bib39","unstructured":"PFO ACCESS Registry. 2017. Available at: https:\/\/clinicaltrials.gov\/show\/NCT00583401. Accessed February 12, 2017."},{"key":"10.1016\/j.iccl.2017.05.007_bib40","unstructured":"GORE HELEX septal occluder\/GORE septal occluder for patent foramen ovale (PFO) closure in stroke patients - The Gore REDUCE Clinical Study (HLX 06\u201303). 2017. Available at: https:\/\/clinicaltrials.gov\/show\/NCT00738894. Accessed February 12, 2017."},{"key":"10.1016\/j.iccl.2017.05.007_bib41","unstructured":"RE-SPECT ESUS Dabigatran etexilate for secondary stroke prevention in patients with embolic stroke of undetermined source. 2017. Available at: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02239120. Accessed March 11, 2017."},{"key":"10.1016\/j.iccl.2017.05.007_bib42","unstructured":"NAVIGATE ESUS Rivaroxaban versus aspirin in secondary prevention of stroke and prevention of systemic embolism in patients with recent embolic stroke of undetermined source (ESUS). 2017. Available at: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02313909. Accessed March 11, 2017."}],"container-title":["Interventional Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745817300731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745817300731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T01:02:48Z","timestamp":1535418168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211745817300731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S2211745817300731"],"URL":"https:\/\/doi.org\/10.1016\/j.iccl.2017.05.007","relation":{},"ISSN":["2211-7458"],"issn-type":[{"value":"2211-7458","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Dataset for Patent Foramen Ovale Closure in Cryptogenic Stroke","name":"articletitle","label":"Article Title"},{"value":"Interventional Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iccl.2017.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}